Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters








Language
Year range
1.
Mem. Inst. Oswaldo Cruz ; 107(7): 888-892, Nov. 2012. tab
Article in English | LILACS | ID: lil-656044

ABSTRACT

Single nucleotide polymorphisms (SNPs) in the interleukin (IL)28B locus have been associated with a sustained virological response (SVR) in interferon-ribavirin (IFN-RBV)-treated chronic hepatitis C virus (HCV)-infected patients in European and African populations. In this study, the genotype frequency of two IL28B SNPs (rs129679860 and rs8099917) in a cohort of chronic HCV-monoinfected patients in Brazil was evaluated and the SNP sufficient to predict the treatment response outcome was determined. A total of 66 naïve genotype-1 chronic HCV-infected patients were genotyped and the associated viral kinetics and SVR were assessed. The overall SVR was 38%. Both the viral kinetics and SVR were associated with rs129679860 genotypes (CC = 62% vs. CT = 33% vs. TT = 18%, p = 0.016). However, rs8099917 genotypes were only associated with SVR (TT = 53% vs. TG = 33% vs. GG = 18%; p = 0.032). In this population, the analysis of a single SNP, rs12979860, successfully predicts SVR in the IFN-RBV treatment of HCV.


Subject(s)
Female , Humans , Male , Middle Aged , Hepatitis C, Chronic/genetics , Interleukins/genetics , Polymorphism, Single Nucleotide/genetics , Antiviral Agents/therapeutic use , Brazil , Cohort Studies , Drug Therapy, Combination , Genotype , Hepacivirus , Hepatitis C, Chronic/drug therapy , Hepatitis C, Chronic/virology , Interferon-alpha/therapeutic use , Polyethylene Glycols/therapeutic use , RNA, Viral/genetics , Recombinant Proteins/therapeutic use , Ribavirin/therapeutic use , Treatment Outcome , Viral Load
SELECTION OF CITATIONS
SEARCH DETAIL